IVACC_BTA fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Intervacc AB engages in the development of novel veterinary vaccines. It markets veterinary vaccines through its subsidiary Nordvacc Läkemedel AB. The company was founded by Jan-Ingmar Flock, Bengt Guss, Kenneth Janzon, and Rune Bergman in 2001 and is headquartered in Stockholm, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
IVACC_BTA does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company